Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 2 | VANDANA MEDICO TRADERSLikely | 4 | ₹42,840 |
| 2 | Schedule 3 | CONTINENTAL DRUG STORESLikely | 2 | ₹13.3 L |
| 3 | Schedule 4 | CONCEPT BIOMEDICALLikely | 2 | ₹51,000 |
| 4 | Schedule 5 | VANDANA MEDICO TRADERSLikely | 1 | ₹2,580 |
| 5 | Schedule 6 | CONTINENTAL DRUG STORESLikely | 2 | ₹64,108.80 |
Tender Value
₹15.5 L
EMD Value
Exempted
Closing Date
20 Sept 2024, 10:00 amClosed
ACYCLOVIR OPHTH OINTMENT 3 percent W by W IN 5GM TUBE
Brinzolamide 1 percent E by D
E by d Hydroxy Propyl Methylcellulose plus Dextran plus Glycerin plus Polysorbate 80 with Polyquad Preservative Eyemist by tear Natural
E by D Latanoprost stable at room temperature BKC free 0.005 percent microemulsion bott of 3ml
Eye Drop Flurbriprofen Sodium ophthalmic sol 0.3 percent E by D
Eye drop Moxifloxacin 0.5 percent with dexamethasone 0.1 percent preservative free only with drop tainer system bottle of 5ml
Eye Drop Tafluprost Preservative Free 00.0015 percent
Eye drops Netasudil 0.02 percent bottle of 3ml
Eye oint Hypermellose 2 percent Hydroxypropyl methylcellulose 2 percent ocular lub
FLUCONAZOLE 0.3 percent W by V EYE DROPS BOTT OF 5 ML
Gatifloxacin 0.3 percent eye drop bott of 5 ml
Moxifloxacin 0.5 percent preservative free eye drops bottle of 5ml
PILOCARPINE NITRATE EYE SOLUTION 2 percent BOTT OF 5 ML
Sodium Chloride 6 percent w by w ointment Tube of 3 gm BOQ Title OPHTHAL MEDICINES
6841791
GEM/2024/B/5343051
Two Packet Bid
ACYCLOVIR OPHTH OINTMENT 3 percent W by W IN 5GM
30 days
Delhi; South West Delhi
Item wise evaluation
PRODUCT
8 documents required · 8 mandatory
3 yrs
₹3
70%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| ACYCLOVIR OPHTH OINTMENT 3 percent W by W IN 5GM TUBE | SOUTH WEST DELHI | 60 | 30 days |
| Brinzolamide 1 percent E by D | SOUTH WEST DELHI | 420 | 30 days |
| E by d Hydroxy Propyl Methylcellulose plus Dextran plus Glycerin plus Polysorbate 80 with Polyquad Preservative Eyemist by tear Natural | E By D Latanoprost Stable SOUTH WEST DELHI At Room Temperature BK | 6,600 | 30 days |
| E by D Latanoprost stable at room temperature BKC free 0.005 percent microemulsion bott of 3ml | SOUTH WEST DELHI | 300 | 30 days |
| Eye Drop Flurbriprofen Sodium ophthalmic sol 0.3 percent E by D | SOUTH WEST DELHI | 240 | 30 days |
| Eye drop Moxifloxacin 0.5 percent with dexamethasone 0.1 percent preservative free only with drop tainer system bottle of 5ml | SOUTH WEST DELHI | 420 | 30 days |
| Eye Drop Tafluprost Preservative Free 00.0015 percent | SOUTH WEST DELHI | 90 | 30 days |
| Eye drops Netasudil 0.02 percent bottle of 3ml | SOUTH WEST DELHI | 282 | 30 days |
| Eye oint Hypermellose 2 percent Hydroxypropyl methylcellulose 2 percent ocular lub | SOUTH WEST DELHI | 30 | 30 days |
| FLUCONAZOLE 0.3 percent W by V EYE DROPS BOTT OF 5 ML | SOUTH WEST DELHI | 30 | 30 days |
| Gatifloxacin 0.3 percent eye drop bott of 5 ml | SOUTH WEST DELHI | 510 | 30 days |
| Moxifloxacin 0.5 percent preservative free eye drops bottle of 5ml | SOUTH WEST DELHI | 840 | 30 days |
| PILOCARPINE NITRATE EYE SOLUTION 2 percent BOTT OF 5 ML | SOUTH WEST DELHI | 12 | 30 days |
| Sodium Chloride 6 percent w by w ointment Tube of 3 gm BOQ Title OPHTHAL MEDICINES | SOUTH WEST DELHI | 30 | 30 days |
Exempted
20 Sept 2024
30 Aug 2024
20 Sept 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6841791.pdf
GEM_BID
boq_2024-08-30-09-09-45_9c9f394e99d0c28f70a7ec7f664582e3.pdf
BOQ
boq_item_sample_file_-10_2024-08-30-09-09-46_69b97902ecedc1acdf12ab79c55fc78c.csv
BOQ
RFP_787b37e5-923b-4e2b-ad081724989781200_PrabhatBarua.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .